Mark Skaletsky

2012

In 2012, Mark Skaletsky earned a total compensation of $391K as Chairman of the Board and Former Member, Office of the Chairman at Catalyst Biosciences.

Compensation breakdown

Option Awards$158,470
Salary$180,000
Other$52,500
Total$390,970

Skaletsky received $180K in salary, accounting for 46% of the total pay in 2012.

Skaletsky also received $158.5K in option awards and $52.5K in other compensation.

Rankings

In 2012, Mark Skaletsky's compensation ranked 9,454th out of 11,487 executives tracked by ExecPay. In other words, Skaletsky earned more than 17.7% of executives.

ClassificationRankingPercentile
All
9,454
out of 11,487
18th
Division
Manufacturing
3,499
out of 4,253
18th
Major group
Chemicals And Allied Products
966
out of 1,203
20th
Industry group
Drugs
725
out of 925
22nd
Industry
Pharmaceutical Preparations
558
out of 700
20th
Source: SEC filing on April 17, 2013.

Skaletsky's colleagues

We found six more compensation records of executives who worked with Mark Skaletsky at Catalyst Biosciences in 2012.

2012

Stephen Hill

Catalyst Biosciences

Chief Executive Officer

2012

Jeffrey Brennan

Catalyst Biosciences

Former Senior Vice President, Business and Commercial Development and Chief Business Officer

2012

Alan Musso

Catalyst Biosciences

Chief Financial Officer

2012

Peter Zorn

Catalyst Biosciences

General Counsel

2012

J deBethizy

Catalyst Biosciences

Chief Executive Officer

2012

David Hosford

Catalyst Biosciences

Vice President, Clinical Development and Regulatory Affairs

You may also like